Early Life
Egor Nikolaevich Kulkov was born on December 7, 1971, in Novosibirsk, Russia. He earned a Master of Science degree from Novosibirsk State University. During his studies, he formed a crucial partnership with Viktor Kharitonin, which would significantly influence his future career.
Rise to Success
In 1993, Kulkov co-founded the trading firm Kreditinform with Viktor Kharitonin. They later moved to Moscow and joined the investment company Profit House, collaborating with Roman Abramovich's Millhouse Capital. In 1999, Kulkov and Kharitonin acquired the UfaVita plant, marking their initial entry into the pharmaceutical sector. Their most significant breakthrough came in 2003 when they established Pharmstandard by consolidating five factories purchased from ICN Pharmaceuticals, with partners including Roman Abramovich. By 2008, Kulkov and Kharitonin had bought out their partners, solidifying their control over Pharmstandard, which expanded to include brands like Arbidol, Complivit, Pentalgin, and Codelac. Pharmstandard also played a crucial role in the COVID-19 pandemic as a producer of the Sputnik V vaccine. Kulkov also holds stakes in Russian pharmaceutical firms like OTCPharm, Biocad, and Generium.
Key Business Strategies
Kulkov's success is rooted in strategic acquisitions and investments within the pharmaceutical sector. He and Kharitonin have been adept at identifying and capitalizing on opportunities, as seen with their early investments and the establishment of Pharmstandard. Furthermore, Kulkov has shown a knack for diversifying his investments, including significant holdings in the British medical technology firm CMR Surgical, known for its Versius surgical robotic system.
Philanthropy
Information on Kulkov's specific philanthropic initiatives is limited in the search results. However, he is known for supporting various charitable initiatives in Russia, focusing on education, healthcare, and environmental conservation. His foundation has funded scholarships and contributed to restoring cultural heritage sites.
